- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gold Stage
Total 18349 results
-
Merete HaedersdalSebacia, Inc.CompletedAcne Vulgaris | MicroparticlesDenmark
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group...CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
NRG OncologyNational Cancer Institute (NCI)CompletedFallopian Tube Carcinoma | Endometrial Serous Adenocarcinoma | Ovarian Carcinoma | Malignant Female Reproductive System Neoplasm | Primary Peritoneal Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA... and other conditionsUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine... and other conditionsUnited States, Korea, Republic of, Canada
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7United States, Canada, Japan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage I Ovarian Cancer AJCC v6 and v7 | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage II Ovarian Cancer AJCC v6 and v7 | Stage IIA Fallopian Tube Cancer AJCC v6 and v7 | Stage IIB Fallopian... and other conditionsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer... and other conditionsUnited States
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Mixed Mesodermal (Mullerian) Tumor | Stage I Ovarian Cancer AJCC v6 and v7 | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage... and other conditionsUnited States, Korea, Republic of
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBreast Cancer | FatigueUnited States
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI); Sanofi; Pfizer; Eastern Cooperative...Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedBreast Cancer | Hot FlashesUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Terminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMalignant MesotheliomaUnited States
-
Novartis PharmaceuticalsNational Cancer Institute (NCI); Canadian Cancer Trials Group; North Central... and other collaboratorsCompletedNeoplasms, BreastUnited States, Belgium, France, Spain, United Kingdom, Croatia, Estonia, India, Italy, Canada, Netherlands, Argentina, Australia, Austria, Czechia, Denmark, Germany, Israel, Japan, Norway, Poland, Russian Federation, Switzerland, Taiwan, Korea, Republic... and more
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 3United States, Argentina, Brazil, Canada, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Pulmotect, Inc.Imperial College Healthcare NHS Trust; VirTus Respiratory Research Ltd; MWB Consulting... and other collaboratorsCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR1 Gene Mutation | FGFR3 Gene AmplificationUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Marmara UniversityCompleted
-
Gitte Fredberg PerssonCompleted
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Metastatic Kidney CarcinomaUnited States
-
Southwest Oncology GroupNovartis; AstraZenecaTerminatedBreast CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompletedBreast CancerCanada, United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung CarcinomaUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedProstate CancerUnited States, Australia, Peru, Puerto Rico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedGastric CancerUnited States
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
CelgeneCompletedSquamous Cell Carcinoma, Non-Small-Cell LungUnited States, Spain, Germany, Italy, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Mucosal Melanoma | Iris Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IV Uveal Melanoma AJCC v7 | Medium/Large Size Posterior Uveal Melanoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology GroupCompletedStage III Colon Cancer | Adenocarcinoma of the ColonUnited States, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI); Southwest Oncology Group; Aptu...CompletedColorectal CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLeukemiaUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
NCIC Clinical Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid Tumor, Protocol Specific | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer